Back to Search Start Over

Mutations in RHOT1 disrupt ER-mitochondria contact sites interfering with calcium homeostasis and mitochondrial dynamics in Parkinson's disease.

Authors :
Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group) [research center]
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) [research center]
Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group) [research center]
Luxembourg Centre for Systems Biomedicine (LCSB): Integrative Cell Signalling (Skupin Group) [research center]
FNR: PEARL (P13/6682797/Krüger), MiRisk-PD (MiRisk‐PD, C17/BM/11676395), CASCAD (7975668), INTER/BMBF/13/04, NCER-PD, FNR9631103. [sponsor]
DFG: KR2119/8‐1, DI 1386/2‐1, FOR2488 [sponsor]
NIH: P41 GM103426 [sponsor]
BMBF: Mito‐PD 031 A 430 A [sponsor]
JPND Courage-PD [sponsor]
Grossmann, Dajana
Berenguer, Clara
Bellet, Marie Estelle
Scheibner, David
Bohler, Jill
Massart, François
Rapaport, Doron
Skupin, Alexander
Fouquier d'Hérouël, Aymeric
Sharma, Manu
Ghelfi, Jenny
Rakovic, Aleksandar
Lichtner, Peter
Antony, Paul
Glaab, Enrico
May, Patrick
Dimmer, Kai Stefan
Fitzgerald, Julia Catherine
Grünewald, Anne
Krüger, Rejko
Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group) [research center]
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) [research center]
Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group) [research center]
Luxembourg Centre for Systems Biomedicine (LCSB): Integrative Cell Signalling (Skupin Group) [research center]
FNR: PEARL (P13/6682797/Krüger), MiRisk-PD (MiRisk‐PD, C17/BM/11676395), CASCAD (7975668), INTER/BMBF/13/04, NCER-PD, FNR9631103. [sponsor]
DFG: KR2119/8‐1, DI 1386/2‐1, FOR2488 [sponsor]
NIH: P41 GM103426 [sponsor]
BMBF: Mito‐PD 031 A 430 A [sponsor]
JPND Courage-PD [sponsor]
Grossmann, Dajana
Berenguer, Clara
Bellet, Marie Estelle
Scheibner, David
Bohler, Jill
Massart, François
Rapaport, Doron
Skupin, Alexander
Fouquier d'Hérouël, Aymeric
Sharma, Manu
Ghelfi, Jenny
Rakovic, Aleksandar
Lichtner, Peter
Antony, Paul
Glaab, Enrico
May, Patrick
Dimmer, Kai Stefan
Fitzgerald, Julia Catherine
Grünewald, Anne
Krüger, Rejko
Publication Year :
2019

Abstract

OBJECTIVE: The outer mitochondrial membrane protein Miro1 is a crucial player in mitochondrial dynamics and calcium homeostasis. Recent evidence indicated that Miro1 mediates calcium-induced mitochondrial shape transition (MiST), which is a prerequisite for the initiation of mitophagy. Moreover, altered Miro1 protein levels have emerged as a shared feature of monogenic and sporadic Parkinson's disease (PD), but, so far, no disease-associated variants in RHOT1 have been identified. RESULTS: Here, for the first time, we describe heterozygous RHOT1 mutations in two PD patients (het c.815G>A; het c.1348C>T) and identified mitochondrial phenotypes with reduced mitochondrial mass in patient-derived cellular models. Both mutations lead to decreased ER-mitochondrial contact sites and calcium dyshomeostasis. As a consequence, energy metabolism was impaired, which in turn lead to increased mitophagy. CONCLUSION: In summary, our data support the role of Miro1 in maintaining calcium homeostasis and mitochondrial quality control in PD.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1134801841
Document Type :
Electronic Resource